Sunday 29 July 2018

Track 8: Pediatric Cardiology

Pediatric cardiology is a branch of medicine deals with heart related problems in new born, infants, children and adolescents. A pediatric cardiologist is a pediatrician who has received extensive training in diagnosing and treating children's cardiac problems. Currently, evaluating and treating the disease condition may begin with the fetus since heart problems can now be detected before birth. Hence this division is actively involved in therapeutic conclusion and treatment of preventing both congenital and acquired heart disease in children. Finally, the division is committed to educating the next generation of physicians and offers advanced training in pediatric cardiology. 

Subtopics Covered under this Track:
Track 8: Pediatric Cardiology


To Submit the abstarct under this track, click on the link: https://cardiologysummit.cardiologymeeting.com/abstract-submission.php
To Register : https://cardiologysummit.cardiologymeeting.com/registration.php
To know more on  #GroupDiscounts contact through E-mail at cardiology@expertscongress.com

Monday 23 July 2018

Track 7: Occupational Heart Disease

Occupational cardiovascular disease or occupational heart disease is the disease of the heart or blood vessels that are caused by working conditions. Certain toxins including carbon disulfide, nitroglycerin and carbon monoxide in the work area are known to cause heart diseases. Additionally extreme heat and cold, exposure to tobacco smoke, depression and occupational stress is the reason for heart disease. Other occupational hazards potentially related to cardiovascular disease include noise exposure at work, shift work and physical activity at work.


Abstracts related to the track Occupational Heart Disease can be submitted for presenting at Cardiology Summit 2018 at Osaka, Japan. For submission follow the link: https://cardiologysummit.cardiologymeeting.com/abstract-submission.php or submit through E-mail at cardiology@expertscongress.com


Tuesday 17 July 2018

Cardio-oncology: An emerging field in Cardiology

Cardio-oncology is the discipline that concentrates on the intersection of heart diseases and cancer. This field is growing at a faster rate because the survivors after cancer therapies are more prone to develop cardiovascular disease. The increase in cancer disease in the world has led to the emergence of numerous chemotherapeutic agents which are under pre-clinical or clinical studies. These agents are potent to cause damage to the heart (cardiotoxicity). Cardiotoxic effects of chemotherapy might be decreased by the concurrent use of angiotensin-converting enzyme inhibitors, angiotensin receptor blockers or beta-blockers. The use of diagnostic imaging, noninvasive stress testing, serum biomarkers, ambulatory blood pressure monitoring and ambulatory cardiac telemetry can help to identify cardiotoxicities and lead to the development of preventative strategies.
Track 6: Cardio-Oncology
Vanesa Gregorietti, Chairman and President Cardiology Society of Buenos Aires Argentina will be the chief guest who will deliver a keynote speech.
Interested in presenting can submit their abstarct for Speaker Presentation through the link:  https://cardiologysummit.cardiologymeeting.com/abstract-submission.php
We welcome your queries. E-mail us at  cardiology@expertscongress.com

Friday 13 July 2018

Cardiovascular Pharmacology-a highlight in Cardiology Summit 2018

Cardiovascular Pharmacology deals with the study of the effects of drugs upon the heart or circulatory system. It mainly contributes to the safety profile of potential new drugs and provides pharmacological data that can be used for optimization of further compounds and the ultimate selection of compounds suitable for clinical development. The cardiac drugs affect the function of the heart in three main ways. They can affect the force of contraction of the heart muscle (inotropic effects), they can affect the frequency of the heart beat or heart rate (chronotropic effects) or they can affect the regularity of the heart beat (rhythmic effects). Drugs can also affect blood vessels by altering the state of compression of the smooth muscle in the vessel wall, altering its diameter and accordingly directing the volume of blood stream. Such medications are classified as vasoconstrictors or vasodilators depending on the smooth muscle lining contraction and relaxation respectively. 


The main highlights under this track: Total circulatory arrest, Pharmacokinetics & pharmacodynamics of anaesthetic drugs, Pharmacokinetics & pharmacodynamics of vasoactive drugs, Cardiovascular drugs, Antiarrhythmic drugs, Market analysis of drugs, Cardiac pharmaceutical agents, Cardiovascular therapeutics.
Submit the abstract through the following link: https://cardiologysummit.cardiologymeeting.com/abstract-submission.php
Interested delegates can register and book their slots. https://cardiologysummit.cardiologymeeting.com/registration.php
To know more E-mail us at cardiology@expertscongress.com



Thursday 12 July 2018

Track 4: Interventional Cardiology and Heart Surgery at Cardiology Summit 2018


Interventional cardiology involves the correction of harmed or debilated vessels, narrowed arteries or other affected parts of the heart structure. It is a non-surgical procedure which uses a small flexible tube called catheter for treatment. The heart can be subjected to many procedures by catheterization. It commonly involves the insertion of catheter into the heart chamber/coronary arteries/valves of cardiac system and cannulating the heart under X-ray visualization or most commonly fluoroscopy. The adaptation of this type of treatment avoids the scars and pain and long post-operative recovery. The procedures involved in interventional cardiology result in substantial patient radiation doses due to prolonged fluoroscopy time and radiographic exposure.
Cardiac surgery or heart surgery is surgery on the heart or great vessels. It is performed in order to correct the problems associated with the heart.  Cardiac surgeon is a specialist in cardiac surgery. Newer methods of heart surgery (such as off-pump and minimally invasive) may reduce risks and speed up recovery time when compared to traditional open heart surgery. A heart specialist performs cardiac surgery to repair or replace heart valves, repair abnormal or damaged structures in the heart, implant medical devices that help control the heartbeat or support heart function and blood flow or to replace a damaged heart with a healthy heart from a donor.  

 

Track 4: Interventional Cardiology and Heart Surgery



Wednesday 11 July 2018

Cardiology Summit 2018: Join as Group and avail special discounts


We are glad to welcome Heart Associations, Organizations, Cardiology Societies and all other cardiology and healthcare professionals from all over the world to join us in large numbers at Osaka, Japan at Cardiology Summit 2018 and make the event successful. 




Interested presenters and delegates can contact the program coordinator at cardiology@expertscongress.com for more details.
https://cardiologysummit.cardiologymeeting.com/registration.php
Avail group discounts!!!!! 
See you all at Osaka, Japan during October 22-23, 2018 !!!!



Friday 6 July 2018

Track 3: Lipid and Metabolic Syndrome


Metabolic syndrome is the major cause that contribute to cardiovascular morbidity and mortality. It is a cluster of metabolic disorders, such as dyslipidemia, abdominal obesity, hypertension and impaired fasting glucose which will increase the risk for cardiovascular disease. The dietary lipids are also recognized to contribute in the development and the prevention of cardiovascular risk clustering. This review explores the relevant mechanisms involved in the influence of dietary fatty acids on metabolic syndrome components.
The important features for metabolic syndrome include hypertension (high blood pressure), insulin resistance, abnormal cholesterol, and an increased risk for clotting. People diagnosed with this syndrome are usually overweight or obese. When it comes to assessing the risk of cardiovascular disease, triglycerides also play a important role due to which dietary advice for people with heart problems usually aims at reducing blood cholesterol especially LDL cholesterol. Therefore, replacing saturated fat with polyunsaturated and monounsaturated fats, and increasing the intake of food products rich in fiber and complex carbohydrates such as whole grains, is usually recommended.
The development of metabolic syndrome mainly due to Genetics and the environmental factors. Approximately 20%-30% of the population in industrialized countries has metabolic syndrome and the people with Metabolic syndrome will have three times higher risk of developing cardiovascular disease. Additionally, statin drugs play a key role in the treatment of people with coronary heart disease, mostly because they lower LDL cholesterol.
The treatment choices include changing lifestyle and weight reduction which usually requires a specifically tailored, multifaceted program that includes diet and exercise. Medications also may be useful.


To submit the abstract under this track: Click Here.
E-mail us at cardiology@expertscongress.com or cardiology2018@gmail.com 
 Submit the abstarct soon. All accepted abstracts will be provided with partial sponsorship upto July 17, 2018. 
Contact us to know more. 

Thursday 5 July 2018

Track 2: Heart and Cardiovascular Diseases

Cardiovascular diseases (CVD) are the leading cause of death globally. These are the class of diseases that involve the heart or blood vessels. It is estimated that 90% of CVD is preventable. Existing cardiovascular disease or a previous cardiovascular event such as a heart attack or stroke is the strongest predictor of a future cardiovascular event. The common symptom of CVD is pain or discomfort in the centre of the chest, in the arms and left shoulder, elbows, jaw or back. Feeling sick or vomiting, difficulty in breathing, feeling light-headed or fainting, breaking into a cold sweat and becoming pale may also be shown as additional symptom. At least three quarters of the world's deaths from CVDs occur in low- and middle-income countries. This is because they do not have the benefit of integrated primary health care programmes for early detection and treatment.



Speaker slots are available!!! Submit the abstract for Track 2: Heart and Cardiovascular Diseases at https://cardiologysummit.cardiologymeeting.com/abstract-submission.php

For queries, contact us at cardiology@expertscongress.com

Wednesday 4 July 2018

Track 1: Cardiology

Cardiology is a branch of medicine which deals with the study of disorders of the heart as well as parts of the circulatory system. This field includes medical diagnosis and treatment of congenital heart defects. Cardiologists are medical doctors who specialize in heart and blood vessel disease. They help in preventing the disease as well as diagnose and treat those who already have them. Cardiology is divided into several fields such as pediatric cardiology, adult cardiology, interventional procedures, electrophysiology and echocardiography etc.
 


Abstract submissions are open! and interested speakers can submit the abstarct to the Tack Cardiology through the link: https://cardiologysummit.cardiologymeeting.com/abstract-submission.php

 

Tuesday 3 July 2018

Contec Medical Systems as Exhibitor at Cardiology Summit 2018

Contec Medical Systems focuses on research, manufacture and distribution of medical instruments.  
Pulse Oximeter, Sphygmomanometer, ECG, EEG, Ultrasound Equipment, Patient Monitor and Image Equipment, are some of the major products produced and distributed by Contec. Currently more than 20 different category of products are produced, 2000000 products per year is distributed to more than 200 countries and regions. 

 


Contec Medical Systems, exhibitor at Global Cardiology Summit which is held at Osaka, Japan.
If any companies are interested to exhibit at our event, they can contact through E-mail at cardiology@expertscongress.com 
For details about exhibition,  visit: https://cardiologysummit.cardiologymeeting.com/exhibition.php

Evidence Supporting Niacin Use for CV Disease Prevention Evaluated

According to the results of a systematic review & meta-analysis, evidence supporting the clinical benefit of niacin monotherapy for se...

Announcement: Cardiology Summit 2018